Exagen Inc.XGNNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank42
5Y CAGR-0.7%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

5Y CAGR
-0.7%/yr
Long-term compound
Percentile
P42
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202517.18%
202412.41%
202337.97%
2022-22.96%
20219.03%
202017.78%
201926.48%
201834.66%
20170.00%
201576.08%